AI in Indian Healthcare Shifts From Experimental Pilots to Real-World Scale
A Bain & Company and HealthQuad report identifies ICU optimization and chronic disease management as the next major growth frontiers.
Artificial intelligence in Indian healthcare is transitioning from isolated experimental pilots to scalable, real-world applications. This shift marks a pivotal moment where AI is evolving from a simple efficiency tool into a practical capacity multiplier for a strained medical infrastructure.
According to a joint report by Bain & Company and HealthQuad titled 'AI in Indian Healthcare Delivery,' the next major growth opportunities lie in remote patient monitoring, OT/ICU optimization, and post-discharge chronic disease management. This acceleration is driven by a dramatic shift in underlying technology; the cost of frontier AI models has fallen approximately 92 percent since 2023. Furthermore, the report notes that the volume of expert-level work AI can complete autonomously has been doubling every six to nine months since 2023.
The Infrastructure Gap
Despite the technological leap, the report highlights a significant structural bottleneck: the adoption of Electronic Medical Records (EMR). Currently, the EMR adoption rate in India stands at 35%, which serves as a primary limiting factor for connected clinical care. Without digitized patient histories, the ability to deploy integrated AI solutions across different care settings remains constrained.
However, the broader ecosystem is becoming more receptive. Indian healthcare providers are increasingly using AI to alleviate administrative burdens on clinicians, supported by a combination of government initiatives and a robust startup environment. This landscape suggests that India is better positioned for AI scaling now than it was during previous waves of digital adoption.
Market Implications
For the industry, the move toward scale opens significant untapped market opportunities. The "whitespaces" in ICU and chronic disease management are particularly lucrative for startups and integrated platforms, especially for hospitals that lack the resources to develop in-house technical capabilities. Namit Chugh, Director at HealthQuad, noted that AI has the potential to change the healthcare equation by acting as a capacity multiplier rather than just a lever for efficiency.
The Path to Adoption
As the technology matures, the focus is shifting from the raw power of the models to the practicality of their implementation. Dhruv Sukhrani, Head of Bain & Company's Healthcare & Life Sciences practice in India, stated that the next phase of adoption will be determined by the ability of providers to combine value, deployability, and trust, rather than simply having access to more advanced AI models.
Industry observers will now be watching whether the increase in EMR penetration can keep pace with AI's autonomous capabilities, as the success of remote monitoring and ICU optimization depends heavily on the availability of high-quality, digitized clinical data.